Balaji Amines Ltd

Balaji Amines Ltd Performance

Day's Price Range
52-Week Price Range
1 Month Return-9.73 %
3 Month Return-29.87 %
1 Year Return-36.14 %

Analyst Rating

based on 2 analysts


Based on 2 analysts offering long term price targets for Balaji Amines Ltd. An average target of ₹4166

Source: S&P Global Market Intelligence

Analyst Forecast

Balaji Amines Ltd price forecast by 2 analysts

Upside of109.87%







Current Price: ₹2006.9

Target Price: ₹4166

Source: S&P Global Market Intelligence

Balaji Amines Ltd Valuation

Balaji Amines Ltd in the last 5 years

Lowest (6.87x)

August 5, 2019

Today (16.63x)

March 20, 2023

Highest (54.52x)

September 14, 2021



Price to Earnings TTM Ratio

Insights on Balaji Amines Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    In the last 1 year, Gujarat Fluorochemicals Ltd has given 6.5% return, outperforming this stock by 41.4%


    Revenue Fall

    Revenue is down for the last 4 quarters, 783.91Cr → 588.47Cr (in ₹), with an average decrease of 9.1% per quarter

Balaji Amines Ltd Shareholding Pattern

InvestorsHoldings %Prev. 4 periods3M change
Promoter Holdings
Foreign Institutions
Mutual Funds
Retail Investors

Balaji Amines Ltd Company Financials

  • Quarterly
  • Annual
Value in ₹ crore

Corporate Announcements

  • Balaji Amines Ltd Earnings Results

    Balaji Amines Ltd’s net profit fell -30.14% since last year same period to ₹62.57Cr in the Q3 2022-2023. On a quarterly growth basis, Balaji Amines Ltd has generated -32.41% fall in its net profits since last 3-months.

    Read More
  • Balaji Amines Ltd Dividends May,2022

    In the quarter ending June 2022, Balaji Amines Ltd has declared dividend of ₹6 - translating a dividend yield of 0.5%.

    Read More

Balaji Amines Ltd Company Information

Promoted by the KPR Group of Industries Balaji Amines Ltd. BAL was incorporated on 27th October 1988. The Company is a leading manufacturer of ethyl and methyl amines which have various applications in chemical industries. It is presently engaged in manufacture and sale of Speciality Chemicals Aliphatic Amines and derivatives. Apart from this it has now diversified into producing derivatives of methyl and ethyl amines namely DiMethyl Amine Hydrochloride DMAHCl Choline Chloride Di Methyl Acetamide etc. At present the Company supply to various Blue Chip Companies like IDI Hoechst Rallis Ion Exchange Cheminor Drugs TTK Pharma etc. It has four manufacturing facilities three plants at Tuljapur and Chincholi in Maharashtra and one at Medak Telangana. It owns a Five Star Hotel in Solapur Maharashtra and has CFL lamps facility at Medak Telangana. The Company presently operates in three segments i.e. Specialty Chemicals and Amines Hotel and CFL Lamps. A new facility for manufacture of Speciality Chemicals is under construction at Chicholi Maharashtra.On May 95 it came out with a public issue of 9.63 lac equity shares premium : Rs 30 aggregating Rs 3.85 cr to partfinance expansion plans for ethylamines and forward integration for the manufacture of derivatives of methyl and ethyl amines totaling to Rs 10 cr. In 1988 the Company started business operations.In 1989 it started to produce Methyl Amines and Ethyl Amines.In 1992 the Company established RD Centre at Hyderabad.In 1995 it started manufacturing drug intermediate Dimethyl Amine Hydrochloride.In 199798 the company has successfully commenced the commercial operation of its main plant Ethyl Amines from June 1997.In 2000 it added derivatives of Methyl and Ethyle Amines to the product portfolio.In 2001 the Company was certified with ISO:9001.Expansion programme has been taken up for valueadded products like Choline Chloride DMAEHCI and other intermediates at a cost of Rs.500 lacs. The project has been appraised by State Bank of Hyderabad and Bank of India for a term loan of Rs.290 lacs and Rs.100 lacs respectively.The balance would be met out by the internal accruals of the company.The project would be implemented on phases and the first phase is likely to be commissioned during the current year 20012002.During the year 2003 Company was awarded Recognized Export House status from Government of India Ministry of Commerce New Delhi. It increased the capacity of Methyl Amines.In 2005 the Company developed more specialty chemicals.In 2006 it founded Balaji Foundation and Research Centre for the rural population as a part of CSR activity. It became the sole manufacturerof GBI NMP and Morpholine.During the year 2009 the Company started power generation through windmill by establishing 1.5 MW windmill unit at Satara Maharashtra. It established an R D GBL Plant at Tamalwadi Solapur. It commenced setting up 2.5 MW CoGeneration Power Plant Unit at Tamalwadi and PVP Plant at Chincholi in Solapur respectively. Apart from this it secured the Certificate of Merit for Outstanding Export by Chemexcil.During the year 2010 2.5 Mw Co Generation Power Plant at Tamalwadi Solapur has been commissioned in July 2009. Besides this the PVP Plant at Chincholi Solapur has started producing various grades and the mandatory approvals are in final stages.In 2010 the Company installed wind turbine for generating inhouse electricity to start focusing on renewable energy.In 2012 the Company received Certificate of Suitability certification from European Directorate for the Quality Medicines Health Care EDQM Europe for its product PVPK30. It also received WHOGMP certification and REACH Registration Evaluation Authorization and Restriction of Chemicals for four products namely Triethylamine Gammabutyrolactone NEthylamine2Pyrrolidone along with the already registered Nmethyl 2 Pyrrolidone NMP. It has been awarded for the category of Best Manufacturer Exporter Medium at the Indian Exporter Excellence Awards 2012 instituted by the Export Credit Guarantee Corporation of India Limited ECGCAn Indian Govt. Undertaking in association with Dun and Bradstreet DB which seeks to recognize leading exporters for their excellence in their respective fields. In October 2013 the Company inaugurated its 129 Room FiveStar Hotel Property Balaji Sarovar Premiere with an investment of Rs. 110 crore. It executed the commissioning of DMF manufacturing Plant. Further two new plants one for the first phase of DiMethyl Amine Hydrochloride DMAHCL with an installed capacity of 7500 MT per annum commissioned in the month of February 2013 and second plant for manufacture of Di Methyl Formamide DMF with an installed capacity of 30000 MT / P. A at MIDC Chincholi Solapur has been commissioned in the month of March 2013. During the year 2013 Companys 5 star Hotel Property started commercially from 1st November 2013 which is being managed by Sarovar Group of Hotels.In 2014 the Company was awarded for Balaji Sarovar Premiums ecofriendly Green technology.During the year 2015 Company successfully recommissioned its DMF plant by strengthening the Carbon Monoxide plan. In 2015 it was awarded another Certificate of Excellence for Balaji Sarovar Premiere from the Trip Advisor on the basis of customer reviews for excellent food service and hospitality.In 2016 it set up a plant to manufacture Acetonitrile.During the year 201718 the subsidiaries of the Company viz. Bhagyanagar Chemicals Limited companys holding 100 and Balaji Greentech Products Limited companys holding 66 were amalgamated with BAL the Company as per the scheme of amalgamation sanctioned by the Honble NCLT Mumbai.In 2018 the Company was 90 acres of land at MIDC Chincholi with Mega Project Status for this new project by Maharashtra State Government. It commissioned a new plant for manufacture of Morpholine and Acetonitrile after successful trial runs.In 2019 the Company set up a new plant under subsidiary Balaji Specialty Chemicals Private Limited. The project was completed in a record 12 months and received Environment Clearance for Greenfield Project as well. It received Environmental Clearance for Balaji Amines Unit IV Greenfield Project.In 2021 Company commenced operation in Greenfield Project at UnitIV.

Balaji Amines Ltd Share Price: ₹2006.90 per share as on 22 Mar, 2023 04:01 PM
Balaji Amines Ltd Market Capitalisation: ₹7,553.32Cr as of today
Balaji Amines Ltd Revenue: ₹588.47Cr as on December 2022 (Q4 22)
Balaji Amines Ltd Net Profit: ₹62.57Cr as on December 2022 (Q4 22)
Balaji Amines Ltd Listing date: 04 May, 2007
Balaji Amines Ltd Chairperson Name: A Prathap Reddy
OrganisationBalaji Amines Ltd
E-voting on sharesClick here to vote

Frequently Asked Questions

Balaji Amines Ltd(BALAMINES) share price today is ₹2006.90 (last updated 22 Mar, 2023 at 04:01 PM)

  • Today’s highest price of Balaji Amines Ltd(BALAMINES) is ₹2034.85.
  • Today’s lowest price of Balaji Amines Ltd(BALAMINES) is ₹2003.00.
  • (last updated 22 Mar, 2023 at 04:01 PM)
Today’s traded volume of Balaji Amines Ltd(BALAMINES) is 25224.
Today’s market capitalisation of Balaji Amines Ltd(BALAMINES) is ₹7,553.32Cr.
Balaji Amines Ltd(BALAMINES)Price
52 Week High₹3844.00
52 Week Low₹1975.00
  • (last updated 22 Mar, 2023 at 04:01 PM)
  • Balaji Amines Ltd(BALAMINES) share price is ₹2006.90 (last updated 22 Mar, 2023 at 04:01 PM). It is down -47.79% from its 52 Week High price of ₹3844.00
    Balaji Amines Ltd(BALAMINES) share price is ₹2006.90 (last updated 22 Mar, 2023 at 04:01 PM). It is up 1.62% from its 52 Week Low price of ₹1975.00
    Balaji Amines Ltd(BALAMINES)Returns (%)
    1 Day Returns0.13%
    1 Month Returns-9.73%
    1 Year Returns-36.14%
    3 Year Returns820.05%
    5 Year Returns240.42%
    Balaji Amines Ltd(BALAMINES) share price is ₹2006.90 and its price to earning (PE) is 16.63. A high PE ratio indicates that a share price is overvalued, or investors are expecting a high growth rate in the future.

    Indian stocks brokerage services are provided by INDmoney Private Limited. INDmoney Private Limited is carrying out the business of in respect to stock broking activities and also carries out the activities of depository participant. SEBI Registration No. INZ000305337 | SEBI Depository Participant Registration No. IN-DP-690-2022 Depository Participant ID: CDSL 12095500 | Trading and Clearing Member of NSE (90267, M70042) and BSE (6779)

    Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. The securities quoted are exemplary and not recommendatory. Past performance is not indicative of future returns.